Erowid References Database
Kim SY, Anderson IB, Dyer JE, Barker JC, Blanc PD.
“High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users”.
Am J Drug Alcohol Abuse. 2007;33(3):429-38.
INTRODUCTION: Little is known about behaviors linked to gamma hydroxybutyrate (GHB) morbidity.
METHODS: We surveyed 131 GHB users, using logistic regression to test the associations between the high risk behaviors and hospital treatment for GHB (26 [20%] of subjects).
RESULTS: Increased risk of GHB hospital treatment was associated with: co-ingestion of ethanol (OR 5.2; 95% CI 1.7-16), driving under the influence of GHB (OR 3.2; 95%, CI 1.3-7.8),use of GHB to treat withdrawal symptoms (OR 2.9; 95% CI 1.1-7.9), and co-ingestion of ketamine (OR 2.7; 95% CI 1.1-6.7).
CONCLUSIONS: Targeted prevention activities could focus on selected high-risk behaviors.
|Notes # : erowid mention
[ Cite HTML